What Is Etoricoxib & Cyclobenzaprine Hydrochloride Tablets (ERITOCOX BENZ 90/5) Used For?
Etoricoxib & Cyclobenzaprine Hydrochloride Tablets combine a selective COX-2 inhibitor with a centrally acting muscle relaxant, giving patients dual-action relief that neither drug can achieve alone. Etoricoxib targets inflammation and pain at the site of injury, while Cyclobenzaprine works on the central nervous system to reduce muscle spasm and improve mobility. This combination is particularly useful for patients whose pain has a strong spasmodic component, such as those recovering from a lifting injury or dealing with chronic low back pain flare-ups.
Why It's Important
Muscle spasm and inflammatory pain frequently occur together, but treating only one component often leaves patients with incomplete relief. A patient given an NSAID alone may still experience stiffness and spasm, while a muscle relaxant alone won't address underlying inflammation. ERITOCOX BENZ 90/5 addresses both simultaneously, reducing the need for multiple separate prescriptions, improving patient compliance, and shortening the overall duration of acute pain episodes. For prescribers, this single-tablet approach simplifies dosing schedules and reduces polypharmacy risk in patients with acute musculoskeletal conditions.
Key Benefits of ERITOCOX BENZ 90/5
What Are the Benefits of This Combination?
- Dual-action relief — addresses both inflammatory pain and muscle spasm in one tablet
- Faster mobility restoration — helps patients return to daily activity sooner by relaxing tight, spasming muscles
- Reduced pill burden — one tablet instead of two separate prescriptions improves adherence
- Targeted COX-2 inhibition — Etoricoxib offers effective anti-inflammatory action with a gastric-friendlier profile compared to non-selective NSAIDs
- Improved sleep quality — Cyclobenzaprine's mild sedative effect can help patients rest better during acute pain episodes
- Short-course suitability — designed for short-term use in acute flare-ups rather than long-term daily therapy
Side Effects
Like all medications, ERITOCOX BENZ 90/5 may cause side effects in some patients. Common, generally mild side effects include:
- Drowsiness or dizziness
- Dry mouth
- Nausea or indigestion
- Headache
- Fatigue
Serious Side Effects of ERITOCOX BENZ 90/5
Patients should seek immediate medical attention if they experience:
- Signs of gastrointestinal bleeding (black stools, vomiting blood)
- Chest pain, irregular heartbeat, or shortness of breath
- Severe allergic reaction (swelling of face/throat, difficulty breathing, skin rash)
- Yellowing of skin or eyes (signs of liver involvement)
- Confusion, blurred vision, or fainting
Available Substitutes for ERITOCOX BENZ 90/5
A substitute should not be selected solely because it contains a similar-sounding combination. Alternatives may contain different strengths, ingredients or therapeutic approaches.
Depending on the diagnosis, a healthcare professional may consider an alternative containing an NSAID, a different muscle relaxant, or another pain-management strategy. The appropriate substitute depends on factors such as the cause and severity of pain, cardiovascular and gastrointestinal risk, kidney or liver function, current medicines and treatment duration.
Dosage Guidelines for ERITOCOX BENZ 90/5
The standard adult dosage is typically one tablet once daily, preferably after food, for a short duration as advised by the physician — generally not exceeding 5–7 days without medical review. Dosage should always be individualized based on the patient's condition, renal/hepatic function, and response to therapy. This medicine should only be taken under medical supervision and is not recommended for self-medication.
Precautions & Warnings
- Not recommended for patients with a history of peptic ulcer disease, active GI bleeding, or severe cardiovascular conditions
- Should be used with caution in elderly patients due to increased sensitivity to sedative effects
- Avoid alcohol consumption during treatment, as it may increase drowsiness and GI risk
- Not advised during pregnancy or breastfeeding unless specifically directed by a physician
- Cyclobenzaprine may impair the ability to drive or operate machinery — patients should assess their response before undertaking such activities
- Should not be co-administered with MAO inhibitors or other CNS depressants without medical guidance
Mechanism of Action
Etoricoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, blocking the production of prostaglandins responsible for inflammation, pain, and fever at the injury site, while largely sparing COX-1-mediated gastric protective functions. Cyclobenzaprine, structurally related to tricyclic compounds, acts primarily at the brainstem level rather than at the muscle itself — it reduces tonic somatic motor activity by influencing both gamma and alpha motor neuron activity, effectively easing muscle spasm without directly affecting neuromuscular junction function. Together, these mechanisms provide complementary relief: peripheral anti-inflammatory action from Etoricoxib and central muscle-relaxant action from Cyclobenzaprine.
Conclusion
ERITOCOX BENZ 90/5 by Steris Healthcare offers a rational, dual-action approach to managing acute musculoskeletal pain with associated muscle spasm, combining the anti-inflammatory strength of Etoricoxib with the spasmolytic action of Cyclobenzaprine Hydrochloride. This makes it a practical short-term therapy option for conditions like acute lower back pain, cervical strain, and sports injuries, helping patients achieve faster, more complete symptomatic relief in a single formulation.
Comments
Post a Comment